Pages that link to "Q41828176"

The following pages link to TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells. (Q41828176):

Displaying 23 items.

• TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis (Q27310034) (← links)
• Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells. (Q33682955) (← links)
• EMT and inflammation: inseparable actors of cancer progression. (Q33869755) (← links)
• Epithelial-mesenchymal transition in cancer metastasis through the lymphatic system (Q33869764) (← links)
• DNA methylation profile of triple negative breast cancer-specific genes comparing lymph node positive patients to lymph node negative patients (Q37285274) (← links)
• Platelet-targeted pharmacologic treatments as anti-cancer therapy (Q38657846) (← links)
• Negative feedback loop between ZBTB7A and TGF-β in breast cancer (Q41143462) (← links)
• RELT family members activate p38 and induce apoptosis by a mechanism distinct from TNFR1. (Q46186295) (← links)
• Corneal Epithelial Cells Exhibit Myeloid Characteristics and Present Antigen via MHC Class II. (Q52329763) (← links)
• Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells. (Q55243365) (← links)
• Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer Cells (Q57810885) (← links)
• The Use of Targeted Next Generation Sequencing to Explore Candidate Regulators of TGF-β1's Impact on Kidney Cells (Q60961215) (← links)
• Calcium Carbonate Nanoparticles Can Activate the Epithelial⁻Mesenchymal Transition in an Experimental Gastric Cancer Model (Q64073633) (← links)
• Serum biomarker panels for the diagnosis of gastric cancer (Q64092279) (← links)
• TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma (Q64246941) (← links)
• Consequences of EMT-Driven Changes in the Immune Microenvironment of Breast Cancer and Therapeutic Response of Cancer Cells. (Q64968059) (← links)
• RASSF10 is frequently epigenetically inactivated in kidney cancer and its knockout promotes neoplasia in cancer prone mice (Q89665151) (← links)
• Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? (Q90010888) (← links)
• RASSF10 Is a TGFβ-Target That Regulates ASPP2 and E-Cadherin Expression and Acts as Tumor Suppressor That Is Epigenetically Downregulated in Advanced Cancer (Q91817154) (← links)
• The Vicious Cross-Talk between Tumor Cells with an EMT Phenotype and Cells of the Immune System (Q92083224) (← links)
• The Epithelial-Myeloid-Transition (EMyeT) of cancer cells as a wrongly perceived primary inflammatory process eventually progressing to a bone remodeling malignancy: the alternative pathway for Epithelial- Mesenchymal-Transition hypothesis (EMT)? (Q92107881) (← links)
• Role of Tumor-Mediated Dendritic Cell Tolerization in Immune Evasion (Q92538625) (← links)
• A Brief Review about the Role of Nanomaterials, Mineral-Organic Nanoparticles, and Extra-Bone Calcification in Promoting Carcinogenesis and Tumor Progression (Q92988209) (← links)